Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acromegaly Therapy
Findings from General Hospital, Department of Cardiology provide new insights into acromegaly therapy
July 10th, 2007
New investigation results, "Pharmacologic therapy in growth hormone disorders and the heart," are detailed in a study published in Current Medicinal Chemistry. According to recent research published in the journal Current Medicinal Chemistry, "Growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis is not only involved in the regulation of somatic growth but also has important physiological functions in adults. Several studies have shown that GH deficiency in adults is associated with abnormalities in body composition, metabolic derangements, and suboptimal physical performance." "Furthermore, GH/IGF-I axis plays an important role in the maintenance...
Source: Drug Law Weekly (2007-07-10)
|
